WallStreetZenWallStreetZen

NASDAQ: RANI
Rani Therapeutics Holdings Inc Stock Ownership - Who owns Rani Therapeutics Holdings?

Insider buying vs selling

Have Rani Therapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Talat ImranChief Executive Officer2023-12-0610,000$2.27
$22.70kBuy
Talat ImranChief Executive Officer2023-12-045,000$2.57
$12.85kBuy
Talat ImranChief Executive Officer2023-11-2920,000$2.05
$41.00kBuy
South Cone Investments Limited Partnership10% Owner2023-11-245,265,165$2.01
$10.58MBuy
Cortes Isidoro Alfonso Quiroga10% Owner2023-11-245,265,165$2.01
$10.58MSell
Jean Luc ButelDirector2023-11-1750,500$2.03
$102.51kBuy
Maulik NanavatyDirector2023-11-16500$1.98
$990.00Buy
Talat ImranChief Executive Officer2023-11-072,500$2.01
$5.02kBuy
Talat ImranChief Executive Officer2023-11-072,500$1.98
$4.95kBuy

1 of 1

RANI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RANI insiders and whales buy or sell their stock.

RANI Shareholders

What type of owners hold Rani Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
South Cone Investments Limited Partnership35.07%18,728,042$37.83MInsider
Moreno Isidoro Quiroga9.87%5,272,750$10.65MInsider
Vanguard Group Inc1.33%709,828$1.43MInstitution
Talat Imran0.93%496,798$1.00MInsider
Nan Fung Group Holdings Ltd0.92%493,584$997.04kInstitution
Alphabet Inc0.84%448,492$905.95kInstitution
Andrew Farquharson0.76%406,768$821.67kInsider
United Services Automobile Association0.58%312,095$630.43kInstitution
Mir Hashim0.51%273,265$552.00kInsider
Svai S. Sanford0.48%258,597$522.37kInsider

1 of 3

RANI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RANI5.42%48.52%Net Buying
PRLD51.83%48.17%Net SellingNet Selling
KPTI54.16%30.17%Net SellingNet Selling
COYA21.47%13.97%
ELDN37.47%62.53%

Rani Therapeutics Holdings Stock Ownership FAQ

Who owns Rani Therapeutics Holdings?

Rani Therapeutics Holdings (NASDAQ: RANI) is owned by 5.42% institutional shareholders, 48.52% Rani Therapeutics Holdings insiders, and 46.06% retail investors. South Cone Investments Limited Partnership is the largest individual Rani Therapeutics Holdings shareholder, owning 18.73M shares representing 35.07% of the company. South Cone Investments Limited Partnership's Rani Therapeutics Holdings shares are currently valued at $37.83M.

If you're new to stock investing, here's how to buy Rani Therapeutics Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.